AZD1722
AZD1722 is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
3
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
8 of 8 finished
0.0%
0 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Dose Finding Study to Treat High Phosphate Levels in the Blood.
A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)
To Evaluate the Effect of AZD1722 on the Pharmacokinetics of Oral Midazolam in Healthy Volunteers
AZD1722 Open Label, Absorption Distribution Metabolism and Excretion Study
Clinical Trials (8)
Dose Finding Study to Treat High Phosphate Levels in the Blood.
A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)
To Evaluate the Effect of AZD1722 on the Pharmacokinetics of Oral Midazolam in Healthy Volunteers
AZD1722 Open Label, Absorption Distribution Metabolism and Excretion Study
A Phase 1 Study to Examine the Effect of Renvela on the Pharmacodynamics of AZD1722
A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations
Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8